UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high‐concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany

Pain practice, 2024-06, Vol.24 (5), p.700-708

2024

Volltextzugriff (PDF)

Topical Ambroxol 20% for the Treatment of Classical Trigeminal Neuralgia – A New Option? Initial Clinical Case Observations

Headache, 2019-03, Vol.59 (3), p.418-429

2019

Volltextzugriff (PDF)

Oral or Topical Pain Therapy—How Would Patients Decide? A Discrete Choice Experiment in Patients with Peripheral Neuropathic Pain

Pain practice, 2021-06, Vol.21 (5), p.536-546

2021

Volltextzugriff (PDF)

Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data

Pain practice, 2017-06, Vol.17 (5), p.678-700

2017

Volltextzugriff (PDF)

Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain

Clinical therapeutics, 2015-01, Vol.37 (1), p.94-113

2015

Volltextzugriff (PDF)

Low back pain management in routine clinical practice: what is important for the individual patient?

Pain management, 2023-04, Vol.13 (4), p.243-252

Kern, Kai-Uwe

2023

Volltextzugriff (PDF)

Ambroxol for neuropathic pain: hiding in plain sight?

Pain (Amsterdam), 2023-01, Vol.164 (1), p.3-13

2023

Volltextzugriff (PDF)

Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?

Pain practice, 2014-02, Vol.14 (2), p.E42-E50

2014

Volltextzugriff (PDF)

Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain

Journal of pain research, 2020-01, Vol.13, p.2585-2597

2020

Volltextzugriff (PDF)

Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of life

Pain management, 2020-03, Vol.10 (2), p.85-95

2020

Volltextzugriff (PDF)

Ambroxol for the treatment of fibromyalgia: science or fiction?

Journal of pain research, 2017-01, Vol.10, p.1905-1929

2017

Volltextzugriff (PDF)

Verbesserte Analgesie, Funktionalität und Lebensqualität unter Tapentadol retard: Subgruppenanalyse einer nicht-interventionellen Studie bei chronischen Schmerzpatienten mit Oxycodon/Naloxon-Vorbehandlung

MMW Fortschritte der Medizin, 2014, Vol.156 (Suppl 13), p.54-63

2014

Volltextzugriff (PDF)

Consensus and Controversies Between Pain and Addiction Experts on the Prevention, Diagnosis, and Management of Prescription Opioid Use Disorder

Journal of addiction medicine, 2020-01, Vol.14 (1), p.1-11

2020

Volltextzugriff (PDF)

Successful treatment of complex regional pain syndrome with topical ambroxol: a case series

Pain management, 2018-11, Vol.8 (6), p.427-436

2018

Volltextzugriff (PDF)

Is physician supervision of the capsaicin 8% patch administration procedure really necessary? An opinion from health care professionals

Journal of pain research, 2013-01, Vol.6 (default), p.571-575

2013

Volltextzugriff (PDF)

The capsaicin 8% patch for peripheral neuropathic pain

British journal of nursing (Mark Allen Publishing), 2011-08, Vol.20 (15), p.926-931

2011

Volltextzugriff (PDF)

Tapentadol versus klassische WHO-III-Opioide bei chronischen Rückenschmerzen

MMW Fortschritte der Medizin, 2022-04, Vol.164, p.19-27

2022

Volltextzugriff (PDF)

Tapentadol versus klassische WHO-III-Opioide bei chronischen Rückenschmerzen: Versorgungsforschungsstudie auf Basis repräsentativer Krankenkassendaten

MMW Fortschritte der Medizin, 2022-04, Vol.164 (Suppl 6), p.19-27

2022

Volltextzugriff (PDF)

REPRINTED WITH PERMISSION OF IASP – PAIN 164 (2023) 3–13: Ambroxol for neuropathic pain: hiding in plain sight?

BÓL, 2023-10, Vol.24 (3), p.21-34

2023

Volltextzugriff (PDF)

Erratum zu: Verbesserte Analgesie, Funktionalität und Lebensqualität unter Tapentadol retard

MMW Fortschritte der Medizin, 2014-08

2014

Volltextzugriff (PDF)

Verbesserte Analgesie, Funktionalität und Lebensqualität unter Tapentadol retard

MMW Fortschritte der Medizin, 2014-07, Vol.156 (13), p.54-63

2014

Volltextzugriff (PDF)

Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone

MMW Fortschritte der Medizin, 2014-07, Vol.156 Suppl 2, p.54-63

2014

Volltextzugriff (PDF)

What is localized neuropathic pain? A first proposal to characterize and define a widely used term

Pain Management, 2012-01, Vol.2 (1), p.71-77

2012

Volltextzugriff (PDF)

Capsaicin 8% patch for peripheral neuropathic pain: review of treatment best practice from 'real-world clinical experience

Pain management (London), 2012-05, Vol.2 (3), p.239-250

2012

Volltextzugriff (PDF)

Tapentadol versus classical WHO-III opioids for chronic back pain. Health services research study based on representative data from health insurance funds

MMW Fortschritte der Medizin, 2022-04, Vol.164 (Suppl 6), p.19

2022

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(21)

Publikationsform

Sprache

Englisch
(25)
Deutsch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Clinical Neurology
(16)
Neurosciences & Neurology
(16)
Humans
(13)
Pain
(9)
Pain Management
(9)
Male
(6)
Neuropathic Pain
(6)
Anesthesiology
(5)
Chronic Pain - Drug Therapy
(5)
Female
(5)
Neuralgia - Drug Therapy
(5)
Pain Measurement
(5)
Aged
(4)
Ambroxol
(4)
Analgesics - Therapeutic Use
(4)
Analgesics, Opioid - Administration & Dosage
(4)
Analgesics, Opioid - Therapeutic Use
(4)
Capsaicin
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high‐concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany

Topical Ambroxol 20% for the Treatment of Classical Trigeminal Neuralgia – A New Option? Initial Clinical Case Observations

Oral or Topical Pain Therapy—How Would Patients Decide? A Discrete Choice Experiment in Patients with Peripheral Neuropathic Pain

Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data

Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain

Low back pain management in routine clinical practice: what is important for the individual patient?

Ambroxol for neuropathic pain: hiding in plain sight?

Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?

Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain

Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of life

Ambroxol for the treatment of fibromyalgia: science or fiction?

Verbesserte Analgesie, Funktionalität und Lebensqualität unter Tapentadol retard: Subgruppenanalyse einer nicht-interventionellen Studie bei chronischen Schmerzpatienten mit Oxycodon/Naloxon-Vorbehandlung

Consensus and Controversies Between Pain and Addiction Experts on the Prevention, Diagnosis, and Management of Prescription Opioid Use Disorder

Successful treatment of complex regional pain syndrome with topical ambroxol: a case series

Is physician supervision of the capsaicin 8% patch administration procedure really necessary? An opinion from health care professionals

The capsaicin 8% patch for peripheral neuropathic pain

Tapentadol versus klassische WHO-III-Opioide bei chronischen Rückenschmerzen

Tapentadol versus klassische WHO-III-Opioide bei chronischen Rückenschmerzen: Versorgungsforschungsstudie auf Basis repräsentativer Krankenkassendaten

REPRINTED WITH PERMISSION OF IASP – PAIN 164 (2023) 3–13: Ambroxol for neuropathic pain: hiding in plain sight?

Erratum zu: Verbesserte Analgesie, Funktionalität und Lebensqualität unter Tapentadol retard

Verbesserte Analgesie, Funktionalität und Lebensqualität unter Tapentadol retard

Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone

What is localized neuropathic pain? A first proposal to characterize and define a widely used term

Capsaicin 8% patch for peripheral neuropathic pain: review of treatment best practice from 'real-world clinical experience

Tapentadol versus classical WHO-III opioids for chronic back pain. Health services research study based on representative data from health insurance funds

Suchergebnisse filtern